Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Clover and Dynavax Announce Planned Global Phase 2/3 Efficacy Trial of Adjuvanted COVID-19 Vaccine Candidate 2021-02-01 14:00
Antengene Announces Collaboration with WuXi Biologics and WuXi STA to Advance Antibody-Drug Conjugate Candidate into Clinical-stage 2021-02-01 08:09
Phase 1 Drug Candidate GLR2007 Developed by Gan & Lee has been Granted Fast Track Designation by the U.S. FDA 2021-01-29 22:53
RedHill Biopharma Announces Positive DSMB Futility Review for Phase 2/3 COVID-19 Study of Opaganib 2021-01-29 20:26
Ascentage Pharma Announces the Fifth Orphan Drug Designation Granted to Bcl-2 Inhibitor APG-2575 by the US FDA, and the Tenth Obtained by the Company 2021-01-29 08:29
RedHill Biopharma Further Expands Opaganib Manufacturing Capacity for COVID-19 with Cosmo Pharmaceuticals 2021-01-28 22:03
Clinical Trial of Proxalutamide's Trial of Hospitalized Covid-19 Patients Was Approved in Brazil 2021-01-28 19:57
Sai Life Sciences announces plans to double headcount and expand capabilities in Manchester, UK 2021-01-28 15:30
Harbour BioMed's Batoclimab (HBM9161) Receives China CDE Breakthrough Therapy Designation for Treatment of Adult Patients with Myasthenia Gravis 2021-01-28 12:54
Mallinckrodt Receives Approval in Japan of the CELLEX® Extracorporeal Photopheresis System for Treatment of Chronic Graft Versus Host Disease 2021-01-28 09:00
Antengene Announces the Acceptance of ATG-010 (Selinexor) NDA by the NMPA for the Treatment of rrMM 2021-01-28 08:00
Antengene Announces the Acceptance of ATG-010 (Selinexor) NDA by the NMPA for the Treatment of rrMM 2021-01-28 08:00
Ajinomoto Bio-Pharma Services and Humanigen Expand Manufacturing Agreement to Support Fill Finish for Investigational COVID-19 Therapeutic, Lenzilumab, Nearing Completion of Phase 3 Study 2021-01-27 20:00
Sihuan Pharmaceutical (0460.HK): Xuanzhu Biopharm acquires Combio Pharmaceutical, the large-molecule integrated development platform helps drive innovation 2021-01-27 11:21
BioVaxys Announces Initiation Of Cancer Vaccine EU Clinical Program, Completion Of BVX-0320 Preclinical Program 2021-01-25 21:00
Boehringer Ingelheim named Top Employer in Malaysia, across Southeast Asia, and South Korea for 2021 2021-01-25 10:00
Boehringer Ingelheim named Top Employer in Vietnam, across Southeast Asia, and South Korea for 2021 2021-01-25 10:00
Boehringer Ingelheim named Top Employer in Philippines, across Southeast Asia, and South Korea for 2021 2021-01-25 10:00
Boehringer Ingelheim named Top Employer in Singapore, across Southeast Asia, and South Korea for 2021 2021-01-25 10:00
Boehringer Ingelheim named Top Employer in Thailand, across Southeast Asia, and South Korea for 2021 2021-01-25 10:00
1 136 137 138 139 140 234